The Vanguard Group, Inc. recently announced the acquisition of new stake in Celsion Corporation (NASDAQ:CLSN). The institutional investor has increased its shareholding in the Healthcare company by 84.83% to 1.33 million shares with purchase of 0.61 million shares. This fresh investment now brings its stake to 4.00% valued currently at $1.46 million. In addition, BlackRock Fund Advisors raised its holdings by 0.57 million to 0.71 million shares. And Renaissance Technologies LLC has lifted its position by 337.87% or 0.53 million shares – to 0.69 million shares.
With over 1.71 million Celsion Corporation (CLSN) shares trading Monday and a closing price of $0.92 on the day, the dollar volume was approximately $1.57 million. The shares have shown a negative weekly performance of -10.44% and its price on 08/31/20 lost nearly -9.56%. Currently, there are 33.23M common shares owned by the public and among those 32.75M shares have been available to trade.
An analysis of what Wall Street brokers have to say about the expected price targets for this stock gives us this picture: 3 analysts who have offered their price forecasts for CLSN have a consensus price objective of $4.21. The analysts have set the share’s price value over the next 12 months at a high of $4.41 and a low of $4.00 should the stock experience a downside. Incidentally, analysts’ outlook for the Celsion Corporation stock is 2.20 for the next 12 months. But an upside of 79.14% will see the stock hit the forecast high price target while mean target price for the stock is $4.21.
Insiders at the company have transacted a total of 7 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 7 of these insider trades were purchases, accounting for 241,500 shares. Insider sales of the common stock occurred on 0 occasions, with total insider shares sold totaling 0 shares.
The top 3 mutual fund holders in Celsion Corporation are Vanguard Total Stock Market Index, Vanguard Extended Market Index Fu, and Fidelity Extended Market Index Fu. Vanguard Total Stock Market Index owns 1.0 million shares of the company’s stock, all valued at over $1.1 million. Fidelity Extended Market Index Fu bought 0.12 million shares to bring its total holdings to over 0.15 million shares at a value of $0.16 million. Fidelity Extended Market Index Fu now owns shares totaling to 0.45% of the shares outstanding.
Shares of Celsion Corporation (NASDAQ: CLSN) opened at $1.01, down -$0.01 from a prior closing price of $1.02. However, the script later closed the day at $0.92, down -9.56%. The company’s stock has a 5-day price change of -10.44% and -66.82% over the past three months. CLSN shares are trading -46.05% year to date (YTD), with the 12-month market performance down to -49.59% lower. It has a 12-month low price of $0.69 and touched a high of $6.50 over the same period. Currently, 1.71 million shares have been traded, compared to an average intraday trading volume of 3.46 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -16.04%, -53.48%, and -44.63% respectively.
Institutional ownership of Celsion Corporation (NASDAQ: CLSN) shares accounts for 17.50% of the company’s 33.23M shares outstanding. Mutual fund holders own 5.31%, while other institutional holders and individual stakeholders account for 7.35% and 1.18% respectively.
It has a market capitalization of $30.39M and a beta (3y monthly) value of 2.09. The earnings-per-share (ttm) stands at -$0.75. Price movements for the stock have been influenced by the stock’s volatility, which stands at 6.25% over the week and 6.58% over the month.
Analysts forecast that Celsion Corporation (CLSN) will achieve an EPS of -$0.13 for the current quarter, -$0.15 for the next quarter and -$0.39 for 2021. The lowest estimate earnings-per-share for the quarter is -$0.18 while analysts give the company a high EPS estimate of -$0.08. Comparatively, EPS for the current quarter was -$0.25 a year ago. Earnings per share for the fiscal year are expected to decrease by -14.20%, and 38.10% over the next financial year.
If you are looking to buy this stock, then you may note that the average analyst recommendation by 3 brokerage firm advisors rate Celsion Corporation (CLSN) as a “Moderate Buy” at a consensus score of 2.20. Specifically, 2 Wall Street analysts polled rate the stock as a buy, while 1 of the 3 advise that investors “hold,” and 0 rated it as a “Sell.”
Looking at the support for the CLSN, a number of firms have released research notes about the stock. Oppenheimer stated their Perform rating for the stock in a research note on July 16, 2020, with the firm’s price target at. Dawson James coverage for the Celsion Corporation (CLSN) stock in a research note released on July 14, 2020 offered a Neutral rating with a price target of. Maxim Group was of a view on October 04, 2017 that the stock is Buy, while Rodman & Renshaw gave the stock Buy rating on April 10, 2017, issuing a price target of $1.50. Maxim Group on their part issued Hold rating on November 10, 2016.